Mirum Pharmaceuticals, Inc. (MIRM)
105.89
+0.73
(+0.69%)
USD |
NASDAQ |
Feb 23, 16:00
107.99
+2.10
(+1.98%)
Pre-Market: 19:59
Mirum Pharmaceuticals Research and Development Expense (Quarterly) : 42.90M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Insmed, Inc. | 254.91M |
| Pfizer Inc. | 3.206B |
| BridgeBio Pharma, Inc. | 112.87M |
| XOMA Royalty Corp. | 0.069M |
| CorMedix, Inc. | 5.098M |